Forte Biosciences, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:FBRX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -10.36 M-10.06 M-14 M-16.47 M-18.81 M -59.34 M Cash from investing activities 36.29 M0-55 K00 -55 K Cash from financing activities -2.32 M70.35 M1.32 M9 00074 K 71.76 M Free cash flow -10.36 M-10.06 M-14 M-16.47 M-18.81 M -59.34 M

News

Forte Biosciences, Inc. (FBRX) Discusses Positive Results From FB102 Phase 1b Vitiligo Study and Mechanism of Action - Slideshow (NASDAQ:FBRX) 2026-07-13

Why Is Forte Biosciences (FBRX) Stock Up Today? - TipRanks.com

FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data

Forte Biosciences: FB102 Is Becoming A Platform Story, Not A Single-Indication Bet (NASDAQ:FBRX)

Forte Biosciences, Inc. (FBRX) Discusses Positive Results From FB102 Phase 1b Vitiligo Study and Mechanism of Action Transcript

Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)

AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)

Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)

Forte Biosciences: Bull Run Could Continue Thanks To Near-Term Data Readouts

Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know

Micron, Insmed among market cap stock movers on Thursday

Evercore ISI initiates coverage on Forte Biosciences stock with Outperform rating